题名

Echinodorus macrophyllus fraction with a high level of flavonoid inhibits peripheral and central mechanisms of nociception

DOI

10.1016/j.jtcme.2021.07.001

作者

Daniele Corrêa Fernandes;Bruna Paiva Martins;Girlaine Pereira da Silva;Eduardo Nunes da Fonseca;Shirley Vânia Moura Santos;Leosvaldo Salazar Marques Velozo;Carlos Roberto Machado Gayer;Kátia Costa de Carvalho Sabino;Marsen Garcia Pinto Coelho

关键词

Medicinal plants ; Chemical ; Thermal and neurogenic assays ; Adrenergic pathway ; NO pathway ; Flavonoid derivatives

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

12卷2期(2022 / 03 / 01)

页次

123 - 130

内容语文

英文

中文摘要

Background and aim: Echinodorus macrophyllus (Kunth.) Micheli is popularly used for acute and chronic inflammatory conditions. The anti-inflammatory activity was previously demonstrated for its flavonoid-enriched fractions. The aim of this work assessed the antinociceptive properties of both aqueous extract and its fractions. Experimental procedure: The antinociceptive activity was determined by acetic acid-induced writhing, formalin test, tail immersion test, hot-plate test, xylene-induced ear edema methods, and the evaluation of its mechanism was performed in the writhing model. The aqueous extract of Echinodorus macrophyllus (AEEm) was fractionated, yielding Fr20, and Fr40. Fr40 composition was determined by HPLC-DAD-ESI-MS. Results and conclusion: Fr20 (all doses) and Fr40 (100 mg/kg) reduced the nociception in the tail-flick model. Both fractions increased the percentage of maximum possible effect with 25 mg/kg, in the hot-plate assay, at 60 min, while AEEm reduced pain only with 50 and 100 mg/kg. There was a reduction in xylene-edema index, with Fr40 (25 mg/kg), AEEm (50 mg/kg) and Fr20 (50 mg/kg). All doses of AEEm, Fr20, and Fr40 reduced both phases of the formalin model. In the abdominal contortion model, Fr40 presented the highest activity, reducing 96% of contortions and its antinociceptive mechanism was evaluated. The results indicated the involvement of NO and adrenergic activation pathways. The main components of Fr40 are swertisin, swertiajaponin, isoorientin 7,3'- dimethyl ether, swertisin-O-rhamnoside, isoorientin, isovitexin, isovitexin-Orhamnoside, and isovitexin- 7-O-glucoside. The aqueous extract of E. macrophyllus leaves and its fractions exhibited significant analgesic effect, mediated through both peripheral and central mechanisms being considered a potentially antinociceptive drug.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. (2008).Plantas medicinais de Mato Grosso - A Farmacopeia Popular dos Raizeiros.Cuiabá, MT, Brazil:
  2. Akindele, AJ,Adeyemi, OO(2007).Antiinflamatory activity of the aqueous leaf extract of Byrsocarpus coccineus.Fitoterapia,78,25-28.
  3. ANVISA(2010).Brazilian Pharmacopoeia. Brazilian Pharmacopeia Convention.Brasília, Brazil:ANVISA.
  4. Banki, E,Hajna, Z,Kemeny, A(2014).The selective PAC1 receptor agonist max-adilan inhibits neurogenic vasodilation and edema formation in the mouse skin.Neuropharmacology,85,538-547.
  5. Bodnar, RJ(2018).Endogenous opiates and behavior: 2016.Peptides,101,167-212.
  6. Bomba, FDT,Wandji, BA,Piegang, BN(2015).Antinociceptive properties of the aqueous and methanol extracts of the stem bark of Petersianthus macrocarpus (P. Beauv.) Liben (Lecythidaceae) in mice.J Ethnopharmacol,174,66-73.
  7. Brandao, MGL,Grael, CFF,Fagg, CW(2011).European naturalists and medicinal plants of Brazil.Biological Diversity and Sustainable Resources Use,Rijeka, Croatia:
  8. Collier, HOJ,Dinneen, LC,Johnson, CA,Schneider, C(1968).The abdominal constriction response and its suppression by analgesic drugs in the mouse.Br J Pharmacol,32,295-310.
  9. Danneman, PJ,Kiritsy-Roy, JA,Morrow, TJ,Casey, KL(1994).Central delay of the laser-activated rat tail-flick reflex.Pain,58,39-44.
  10. Dessaint, J,Yu, W,Krause, JE,Yue, L(2004).Yohimbine inhibits firing activities of rat dorsal root ganglion neurons by blocking Na+ channels and vanilloid VR1 receptors.Eur J Pharmacol,485,11-20.
  11. Ekor, M(2014).The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.Front Pharmacol,4,177.
  12. Fernandes, DC,Martins, BP,Medeiros, DLF(2019).Antinociceptive and anti-inflammatory activities of the hexanic extract of Echinodorus macrophyllus (Kunth.) Micheli in mice.Bras J Health Biom Sci,18,25-32.
  13. Fernandes, DC,Velozo, LSM,Alves, RA(2012).Antinociceptive activity of essential oil from Echinodorus macrophyllus (Kunth.) Micheli (Alismataceae).Rev Fitos,7,245-251.
  14. Gebhart, GF(ed.),Schmidt, RF(ed.)(2013).Encyclopedia of Pain.Berlin, Heidelberg:Springer.
  15. Gilsbach, R,Hein, L(2012).Are the pharmacology and physiology of alpha(2) adrenoceptors determined by alpha(2)-heteroreceptors and autoreceptors respectively?.Br J Pharmacol,165,90-102.
  16. Gong, N,Huang, Q,Chen, Y,Xu, M,Ma, S,Wang, Y(2014).Pain assessment using the rat and mouse formalin tests.Bio-protocol,4,e1288.
  17. Gregory, N,Harris, AL,Robinson, CR,Dopugherty, PM,Fuchs, PN,Sluka, KA(2013).An overview of animal models of pain: disease models and outcome measures.J Pain,14,1255-1269.
  18. He, M,Min, JW,Kong, WL,He, XH,Li, JX,Peng, BW(2016).A review on the pharmaco-logical effects of vitexin and isovitexin.Fitoterapia,115,74-85.
  19. Heyneman, CA,Lawless-Liday, C,Wall, GC(2000).Oral versus topical NSAIDs in rheumatic diseases: a comparison.Drugs,60,555-574.
  20. Hunskaar, S,Hole, K(1987).The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.Pain,30,103-114.
  21. Jain, NK,Kulkarni, SK(1999).NAME L-. A nitric oxide synthase inhibitor, modulates cholinergic antinociception.Methods Find Exp Clin Pharmacol,21,161-165.
  22. Kobayashi, J,Sekiguchi, M,Shigemori, H,Ohsaki, A(2000).Echinophyllins A and B, novel nitrogen-containing clerodane diterpenoids from Echinodorus macrophyllus.Tetrahedron Lett,41,2939-2943.
  23. Koster, R,Anderson, M,de Beer, EJ(1959).Acetic acid for analgesic screening.Fed Proc,18,412.
  24. Liang, X,Liu, R,Chen, C,Ji, F,Li, T(2016).Opioid system modulates the immune function: a review.Transl Perioper & Pain Med,1,5-13.
  25. Lopes, CL,Albano, F,Laranja, GAT(2000).Toxicological evaluation by in vitro and in vivo assays of an aqueous extract prepared from Echinodorus macrophyllus leaves.Toxicol Lett,116,189-198.
  26. Loro, JF,Del Rio, I,Pérez-Santana, L(1999).Preliminary studies of analgesic and anti-inflammatory properties of Opuntia dillenii aqueous extract.J Ethnopharmacol,67,213-218.
  27. Luyen, BTT,Tai, BH,Thao, NP,Cha, JY,Lee, YM,Kim, YH(2014).A new phenolic component from Triticum aestivum Sprouts and its effects on LPS-stimulated production of nitric oxide and TNF-a in RAW 264.7 cells.Phytother Res,28,1064-1070.
  28. Mason, NJ,Artis, D,Hunter, CA(2004).New lessons from old pathogens: what parasitic infections have taught us about the role of nuclear factor-kB in the regulation of immunity.Immunol Rev.,201,48-56.
  29. Pinto, AC,Rego, GC,Siqueira, AM(2007).Immunosuppressive effects of Echinodorus macrophyllus aqueous extract.J Ethnopharmacol,111,435-439.
  30. Prando, TBL,Barboza, LN,Araújo, VO(2016).Involvement of bradykinin B2 and muscarinic receptors in the prolonged diuretic and antihypertensive properties of Echinodorus grandiflorus (Cham. & Schltdl.) Micheli.Phytomedicine,23,1249-1258.
  31. Quintão, NLM,Meyre-Silva, C,Silva, GF(2011).Aleurites moluccana (L.) Willd. leaves: mechanical antinociceptive properties of a standardized dried extract and its chemical markers.Evid Based Complement Alternat Med,1-10.
  32. Quintão, NML,Antonialli, CS,Silva, GF(2012).Aleurites moluccana and its main active ingredient, the flavonoid 2’’-O-rhamnosylswertisin, have promising antinociceptive effects in experimental models of hypersensitivity in mice.Pharmacol Biochem Behav,102,302-311.
  33. Richardson, JD,Vasko, MR(2002).Cellular mechanisms of neurogenic inflammation.J Pharmacol Exp Therapeut,302,839-845.
  34. Sakurada, T,Manome, Y,Tan-No, K(1996).Involvement of nitric oxide in spinally mediated capsaicin and glutamate-induced behavioural responses in the mouse.Neurochem Int,29,271-278.
  35. Salter, M,Strijbos, FPJLM,Neale, S,Duffy, C,Follenfant, RL,Garthwaites, J(1996).The nitric oxide-cyclic GMP pathway is required for nociceptive signaling at specific loci within the somatosensory pathway.Neuroscience,73,649-655.
  36. Sawynok, J(2003).Topical and peripherally acting analgesics.Pharmacol Rev,55,1-20.
  37. Schnitzler, M,Petereit, F,Nahrsted, A(2007).Trans-Aconitic acid, glucosyl flavones and hydroxycinnamoyl tartaric acids from the leaves of Echinodorus grandifloras ssp. aureus, a Brazilian medicinal plant.Rev Bras Farmacogn,17,149-154.
  38. Sewell, RDE,Spencer, PSJ(1976).Antinociceptive activity of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats.Neuropharmacology,15,683-688.
  39. Shibata, M,Ohkubo, T,Takahashi, H,Inok, R(1989).Modified formalin test: characteristic biphasic pain response.Pain,38,347-352.
  40. Shigemori, H,Shimamoto, S,Sekiguchi, M(2002).New cembrane diterpenoids with an eight-membered lactone ring from the leaves of Echinodorus macrophyllus.J Nat Prod,65,82-84.
  41. Shilo, Y,Pascoe, PJ(2014).Anatomy, physiology, and Pathophysiology of pain.Pain Management in Veterinary Practice
  42. Silva, GP,Fernandes, DC,Vigliano, MV(2016).Flavonoid-enriched fraction from Echinodorus macrophyllus aqueous extract exhibits high in-vitro and in-vivo anti-inflammatory activity.J Pharm Pharmacol,68,1584-1596.
  43. Silva, TM,Miranda, RRS,Ferraz, VP,Pereira, MT,Siqueira, EP,Alcântara, AFC(2013).Changes in the essential oil composition of leaves of Echinodrus macrophyllus exposed to γ-radiation.Rev Bras Farmacog,23,600-607.
  44. Spector, J(ed.),Back, N(ed.)(1989).Pharmacological Methods in the Control of Inflammation.New York:
  45. Strada, CL,Lima, KC,da Silva, VC(2017).Isovitexin as marker and bioactive compound in the antinociceptive activity of the Brazilian crude drug extracts of Echinodorus scaber and E. grandiflorus.Rev Bras Farmacogn,27,619-626.
  46. Tannus-Rangel, E,Santos, SR,Lima, JCS(2010).Topical and systemic anti-inflammatory effects of Echinodorus macrophyllus (Kunth.) Micheli (Alismata-ceae).J Med Food,13,1161-1166.
  47. Tita, B,Abdel-Haq, H,Vitalone, A,Mazzanti, G,Saso, L(2011).Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test.Farmaco,56,341-343.
  48. Vaz, MSM,Vaz da Silva, MS,Oliveira, RJ(2016).Evaluation of the toxicokinetics and apoptotic potential of ethanol extract from Echinodorus macrophyllus leaves in vivo.Regul Toxicol Pharmacol,82,32-38.
  49. Vidal, LS,Alves, AM,Kuster, RM,Lage, C,Leitão, AC(2010).Genotoxicity and mutage-nicity of Echinodorus macrophyllus (chapéu-de-couro) extracts.Genet Mol Biol,33,549-557.
  50. Voilley, N.(2004).Acid-sensing ion channels (ASICs): new targets for the an algesic effects of Non-Steroid Anti-Inflammatory Drugs (NSAIDs).Curr Drug Targets-Inflamm Allergy,3,71-79.